These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32189095)

  • 21. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
    Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
    Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
    Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
    BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
    Parlato C; Barbarisi M; Moraci M; Moraci A
    Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma: patterns of recurrence and efficacy of salvage treatments.
    Oh J; Sahgal A; Sanghera P; Tsao MN; Davey P; Lam K; Symons S; Aviv R; Perry JR
    Can J Neurol Sci; 2011 Jul; 38(4):621-5. PubMed ID: 21672702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.
    Walker GV; Gilbert MR; Prabhu SS; Brown PD; McAleer MF
    J Neurooncol; 2013 Mar; 112(1):83-9. PubMed ID: 23266723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiographic patterns of relapse in glioblastoma.
    Chamberlain MC
    J Neurooncol; 2011 Jan; 101(2):319-23. PubMed ID: 21052776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
    Kesari S; Ram Z;
    CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
    Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
    J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gliosarcomas in the elderly: analysis of 7 cases and clinico-pathological remarks.
    di Norcia V; Piccirilli M; Giangaspero F; Salvati M
    Tumori; 2008; 94(4):493-6. PubMed ID: 18822684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
    Jin MC; Liu EK; Shi S; Gibbs IC; Thomas R; Recht L; Soltys SG; Pollom EL; Chang SD; Hayden Gephart M; Nagpal S; Li G
    Front Oncol; 2020; 10():337. PubMed ID: 32219069
    [No Abstract]   [Full Text] [Related]  

  • 35. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
    Younis SG; Khedr RA; El-Shorbagy SH
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Outcomes of Multidisciplinary Management of Gliosarcoma: A Single-Center Study, 2000-2013.
    Jain A; Correia J; Schweder P; McMahon A; Merola J; Aspoas R
    World Neurosurg; 2017 Oct; 106():30-36. PubMed ID: 28642179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model.
    Scott AW; Tyler BM; Masi BC; Upadhyay UM; Patta YR; Grossman R; Basaldella L; Langer RS; Brem H; Cima MJ
    Biomaterials; 2011 Apr; 32(10):2532-9. PubMed ID: 21220172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.